Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
CROs Mercachem, Syncom to merge
by Rick Mullin
September 4, 2017
| A version of this story appeared in
Volume 95, Issue 35
The Dutch pharmaceutical contract research organizations (CROs) Mercachem and Syncom have merged to form Mercachem-Syncom, which has 300 employees—250 of whom are chemists—at facilities in the Netherlands and the Czech Republic. The new company is backed by the investment firm Gilde Healthcare and the pension fund service provider PGGM. It plans further expansion through acquisition and organic growth. “The pharmaceutical industry is demanding a huge bandwidth of highly complex chemistry solutions,” says Syncom CEO Ton Vries.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X